The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

Domenico Mattoscio, Chiara Casadio, Marzia Fumagalli, Mario Sideri, Susanna Chiocca

Research output: Contribution to journal › Article

9 Citations (Scopus)

Abstract

Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

Original languageEnglish
Article number534
Journalecancermedicalscience
Volume9
DOIs
Publication statusPublished - Apr 29 2015

Fingerprint

Papillomavirus Infections
Ubiquitin
Biomarkers
Enzymes
Uterine Cervical Neoplasms
Epithelium
Neoplasms

Keywords

  • Biomarker
  • Cervical cancer
  • HPV
  • HSIL
  • LSIL
  • SUMO
  • Ubc9

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. / Mattoscio, Domenico; Casadio, Chiara; Fumagalli, Marzia; Sideri, Mario; Chiocca, Susanna.

In: ecancermedicalscience, Vol. 9, 534, 29.04.2015.

Research output: Contribution to journal › Article

Mattoscio, D, Casadio, C, Fumagalli, M, Sideri, M & Chiocca, S 2015, 'The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections', ecancermedicalscience, vol. 9, 534. https://doi.org/10.3332/ecancer.2015.534
Mattoscio D, Casadio C, Fumagalli M, Sideri M, Chiocca S. The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. ecancermedicalscience. 2015 Apr 29;9. 534. https://doi.org/10.3332/ecancer.2015.534
Mattoscio, Domenico ; Casadio, Chiara ; Fumagalli, Marzia ; Sideri, Mario ; Chiocca, Susanna. / The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. In: ecancermedicalscience. 2015 ; Vol. 9.
@article{ea33fbde5f0a45ce8e3841ad78891d02,
title = "The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections",
abstract = "Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.",
keywords = "Biomarker, Cervical cancer, HPV, HSIL, LSIL, SUMO, Ubc9",
author = "Domenico Mattoscio and Chiara Casadio and Marzia Fumagalli and Mario Sideri and Susanna Chiocca",
year = "2015",
month = "4",
day = "29",
doi = "10.3332/ecancer.2015.534",
language = "English",
volume = "9",
journal = "ecancermedicalscience",
issn = "1754-6605",
publisher = "Cancer Intellilgence",

}

TY - JOUR

T1 - The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

AU - Mattoscio, Domenico

AU - Casadio, Chiara

AU - Fumagalli, Marzia

AU - Sideri, Mario

AU - Chiocca, Susanna

PY - 2015/4/29

Y1 - 2015/4/29

N2 - Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

AB - Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

KW - Biomarker

KW - Cervical cancer

KW - HPV

KW - HSIL

KW - LSIL

KW - SUMO

KW - Ubc9

UR - http://www.scopus.com/inward/record.url?scp=84930588519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930588519&partnerID=8YFLogxK

U2 - 10.3332/ecancer.2015.534

DO - 10.3332/ecancer.2015.534

M3 - Article

AN - SCOPUS:84930588519

VL - 9

JO - ecancermedicalscience

JF - ecancermedicalscience

SN - 1754-6605

M1 - 534

ER -

Access to Document